Compare Hut 8 Corp (HUT) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hut 8 Corp vs Regeneron Pharmaceuticals Inc — how do they compare? Hut 8 Corp trades at $109.49 (market cap $11.36B), while Regeneron Pharmaceuticals Inc trades at $680.5 (market cap $70.47B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 6.2× Hut 8 Corp's market cap, and Regeneron Pharmaceuticals Inc pays a 0.56% dividend while Hut 8 Corp pays none. Which is the better fit depends on your goals.
| HUT | REGN | |
|---|---|---|
Market Cap | $11.36B | $70.47B |
Sector | Technology | Health |
52-Week High | $133.02 | $812.27 |
52-Week Low | $19.45 | $545.46 |
Enterprise Value | $11.63B | $64.42B |
Dividend Yield | — | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hut 8 Corp
Hut 8 is one of North America's largest digital asset miners and infrastructure providers. It operates diversified data centers supporting Bitcoin mining and high-performance computing (HPC) for AI.
Read more on HUT →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
